Search results
Create the page "Pharmaceuticals" on this wiki! See also the search results found.
- * [[Roche Pharmaceuticals]]5 KB (715 words) - 16:14, 20 March 2015
- ...Zenopa [http://www.zenopa.com/news_story.php?id=18021894 Meda completes 3M Pharmaceuticals acquisition in Europe] Accessed 15th December 2007</ref> ...0GE3E02LECIE20S5D5_assetId=1170423557934 3M Reaches Agreements to Sell its Pharmaceuticals Business] Accessed 15th December 2007</ref>3 KB (423 words) - 15:40, 4 May 2016
- ...2000. He is also Board member of [[Gambro]] AB, [[Active]] AB and [[Innate Pharmaceuticals]] AB.3 KB (452 words) - 12:36, 16 December 2007
- * [[Anthony C Hooper]] - President, U.S. Pharmaceuticals since January 2004. Hooper's biography states that ...Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With Isis Pharmaceuticals] Accessed 16th December 2007</ref>.21 KB (2,852 words) - 14:40, 29 January 2015
- ...panies' as its clients, which include [[Abbott]], [[AstraZeneca]], [[Bayer Pharmaceuticals]], [[Bayer Diagnostics]], [[Bristol-Myers Squibb]], [[Eli Lilly]], [[GlaxoS9 KB (1,198 words) - 19:41, 20 November 2008
- [[Amylin Pharmaceuticals]] [[Solvay Pharmaceuticals]]20 KB (2,176 words) - 14:41, 30 October 2008
- ...a Trustee of [[Cold Spring Harbor Laboratories]] and a Founder of [[FoldRx Pharmaceuticals Inc.]]. Lindquist is affiliated with the [[Whitehead Institute]] (since 200 ...then as a Member of the Executive Committee and Worldwide Chairman for J&J Pharmaceuticals Group in 2001. In 2003 she was named Worldwide Chairman (Medicines & Nutrit22 KB (2,962 words) - 12:56, 18 December 2017
- ...kermes]], [[Mitsubishi Pharmaceuticals]], [[Warner-Lambert]] and [[Momenta Pharmaceuticals]]. He has also written over 860 articles in the medical and scientific fiel6 KB (928 words) - 23:52, 9 July 2009
- ...rn Medical School. He is a member of the board of directors of [[Regeneron Pharmaceuticals Inc.]]. Gilman previously served ten years with the [[University of Virgini * [[Amylin Pharmaceuticals Inc.]] - Commercialization alliance, development and commercialization of d27 KB (3,667 words) - 14:38, 12 July 2016
- ...orporation, [[Ortho-McNeil Pharmaceutical]], [[Pfizer]], Inc. and [[Zeneca Pharmaceuticals]]' (now known as [[AstraZeneca]]).8 KB (1,246 words) - 14:10, 10 January 2008
- ...ew Jersey]]. Haasan has also in the past worked for [[Wyeth]] and [[Sandoz Pharmaceuticals]] (now [[Novartis]]).3 KB (467 words) - 11:58, 20 March 2008
- [[3m Pharmaceuticals]] [[Merck Pharmaceuticals]]4 KB (463 words) - 17:22, 18 February 2008
- ...physician Dr [[Wallace Abbott]]. Abbott's principal businesses are global pharmaceuticals, nutritional and medical products. It describes itself as 'a broad-based he ...S/80.10.10:10/general_content/General_Content_00340.htm Our Partnerships - Pharmaceuticals] Accessed 5th January 2008</ref> <ref>Abbott Laboratories [http://www.abbot10 KB (1,316 words) - 14:10, 12 July 2016
- *[[AstraZeneca]] Pharmaceuticals LP3 KB (454 words) - 11:30, 18 August 2013
- Wyeth describes itself as 'a global leader in pharmaceuticals, consumer health care products, and animal health care products'<ref> Wyeth ...Research and Manufacturers of America]] and 13 years service with [[Sandoz Pharmaceuticals Corporation]] (where he was named Chief Operating Officer in 1988).18 KB (2,630 words) - 14:59, 13 July 2016
- #redirect[[3M Pharmaceuticals]]31 bytes (3 words) - 18:51, 22 April 2008
- * [[Bayer]] Pharmaceuticals1 KB (181 words) - 17:54, 13 February 2008
- ...ion with [[Sandoz Pharmaceuticals]] (now [[Novartis]]) as head of its U.S. pharmaceuticals business. Hassan has also served as chairman of the Board of Directors of t ...search, sales and product management during a 10-year career with [[Sandoz Pharmaceuticals]] (now known as [[Novartis]]). Cox is reported to have been listed as one o12 KB (1,658 words) - 14:24, 10 June 2009
- ...he community Register of medicinal products http://ec.europa.eu/enterprise/pharmaceuticals/register/index.htm Accessed 29/02/08 </ref>574 bytes (88 words) - 10:51, 18 May 2008
- ...ttp://ec.europa.eu/enterprise/pharmaceuticals/mra/doc/statusreport20030717 Pharmaceuticals: regulatory framework and market authorisations.pdf] Accessed 1/03/08 </ref1,007 bytes (134 words) - 10:48, 18 May 2008